Financials

News Ideas Minds Technicals

6549 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to TAIWANJ PHARMACEUTICALS CO LTD operating, investing, and financing activities

6549 free cash flow for H2 23 is -14.13 M TWD. For 2023, 6549 free cash flow was 254 k TWD and operating cash flow was 1.7 M TWD.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—